Kingstone Capital Partners Texas, LLC Novavax Inc Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
A detailed history of Kingstone Capital Partners Texas, LLC transactions in Novavax Inc stock. As of the latest transaction made, Kingstone Capital Partners Texas, LLC holds 161,304 shares of NVAX stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161,304Holding current value
$1.13 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
305Shares Held
90.1MCall Options Held
5.76MPut Options Held
6.65M-
Vanguard Group Inc Valley Forge, PA15.7MShares$110 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.9 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$77.9 Million33.15% of portfolio
-
State Street Corp Boston, MA7.04MShares$49.3 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$26.9 Million0.13% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $548M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...